Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost all cancer types and cause intractable cancers such cases found in ovarian cancer, uterine cancer, esophageal cancer, etc. The p53 gene […]
EVERSANA, a leading provider of global commercial services to the life sciences industry, today unveiled a new full-service affiliate in its EVERSANA INTOUCH global agency network, EVERSANA INTOUCH Healthware. Today’s announcement comes following the October 2023 acquisition of Healthware Group, an agency and innovation consultancy headquartered in Salerno, Italy. The new affiliate will operate from multiple offices across Italy, Finland, the United Kingdom and the United States, […]
BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the AI-driven revolution in drug discovery. BOSTON, Sept. 22, 2023 /PRNewswire/ — The report highlights a […]
Vial, a global full-service CRO providing tech-forward clinical trial management services, announced its participation as a sponsor and speaker at the 4th Annual Gene Therapy for Ophthalmic Disorders Conference in Boston, MA, October 3-5, 2023, at the Hilton Boston Back Bay. The 4th Annual Gene Therapy for Ophthalmic Disorders Conference is a preeminent event that […]
